Home › Forums › General Discussion › Force degradation studies for MDI Formulation in Brasil
Does anyone have information/rational/experience for conducting forced degradation studies on MDI formulations to meet Brazil RDC53 regulations?
Posted on behalf of Sylvine P. at GSK.
Hi Sylvine,
Some of these references may prove helpful. I’ll post your question in the discussion forum to see if other Stabilitarians might comment.
Best regards, John O’Neill StabilityHub Editor
http://docplayer.net/38760118-Forced-degradation-studies-comparison-between-ich-ema-fda-and-who-guidelines-and-anvisa-s-resolution-rdc-53-2015.html
ANVISA’s Guidance on Forced Degradation Studies Explained
ANVISA’s Guidance on Forced Degradation Studies Explained – Part 2
ANVISA’s Guidance on Forced Degradation Studies Explained – Part 3
New developments in the pharmaceutical stress testing industry